Pfizer Says FDA Has Given Green Signal for Virtual Clinical Study

by Kathy Jones on  June 9, 2011 at 6:25 PM Corporate News
RSS Email Print This Page Comment
Font : A-A+

Pharmaceutical giant Pfizer has revealed that it has received the go-ahead signal by the US Food and Drug Administration to conduct the first ever virtual clinical study in the country.
 Pfizer Says FDA Has Given Green Signal for Virtual Clinical Study
Pfizer Says FDA Has Given Green Signal for Virtual Clinical Study

This will be the first such study in the country with both Pfizer and FDA keen to find out whether participating from home via the internet, instead of repeatedly visiting the hospital, will prove to be financially effective.

Pfizer will be testing out its overactive bladder drug, Detrol, and revealed that over 600 patients from 10 states will fill out questionnaire forms through the internet and the company will then be mailing them Detrol or dummy pills. The patients will also be required to submit any changes in their symptoms through the internet.

Commenting on the study, Pfizer's senior vice president, Briggs Morrison said, "This approach, if proven successful, holds considerable promise in speeding up clinical trials while improving their quality."

Source: Medindia

Post a Comment

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
Notify me when reply is posted
I agree to the terms and conditions

More News on:

Top Ten Selling Drugs 

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Advertisement
Advertisement

Stay Connected

  • Available on the Android Market
  • Available on the App Store

Facebook

News Category

News Archive